ログイン
ランキング
お知らせ
ログイン
文献詳細
増大特集 認知症の危険因子と防御因子
文献概要
アパシーは1990年Marinの報告から注目された比較的新しい概念であるが，認知症疾患をはじめ中枢神経疾患で普遍的に認められ，患者自身の生活の質の低下や介護者負担をきたし，リハビリテーションの阻害因子となる。さらに軽度認知障害から認知症への進展・増悪因子としても重要である。アルツハイマー病，脳卒中，パーキンソン病およびレヴィ小体型認知症を中心に，認知症の前駆症状としてのアパシーの重要性とその対策について解説する。
参考文献
1)Marin RS: Differential diagnosis and classification of apathy. Am J Psychiatry 1147: 22-30, 1990
2)Starkstein SE, Petracca G, Chemerinski E, Kremer J: Syndromic validity of apathy in Alzheimer's disease. Am J Psychiatry 158: 872-877, 2001
3)Levy R, Czernecki V: Apathy and the basal ganglia. J Neurol 253 (Suppl 7): VII54-VII61, 2006
4)Levy R, Dubois B: Apathy and the functional anatomy of the prefrontal cortex-basal ganglia circuits. Cereb Cortex 16: 916-928, 2006
5)山口修平: アパシー（意欲障害）とは—神経内科の立場から. 小林祥泰（編）: 脳疾患によるアパシー（意欲障害）の臨床. 新興医学出版社, 東京, 2008, pp3-8
6)岡田和悟, 山口修平: 脳卒中リハビリテーションの新しい展開: うつ, アパシー. 総合リハ39: 1165-1170, 2011
7)小林祥泰: 脳血管障害におけるアパシー（意欲障害）. 小林祥泰（編）: 脳疾患によるアパシー（意欲障害）の臨床. 新興医学出版社, 東京, 2008, pp61-68
8)Robert PH, Onyike CU, Leentjens AF, Dujardin K, Aalten P, et al: Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders. Eur Psychiatry 24: 98-104, 2009
9)Levy ML, Cummings JL, Fairbanks LA, Masterman D, Miller BL, et al: Apathy is not depression. J Neuropsychiatry Clin Neurosci 10: 314-319, 1998
10)Grool AM, Geerlings MI, Sigurdsson S, Eiriksdottir G, Jonsson PV, et al: Structural MRI correlates of apathy symptoms in older persons without dementia: AGES-Reykjavik Study. Neurology 82: 1628-1635, 2014
11)Yan H, Onoda K, Yamaguchi S: Gray matter volume changes in the apathetic elderly. Front Hum Neurosci 9: 318, 2015
12)Onoda K, Yamaguchi S: Dissociative contributions of the anterior cingulate cortex to apathy and depression: Topological evidence from resting-state functional MRI. Neuropsychologia 77: 10-18, 2015
13)Theleritis C, Politis A, Siarkos K, Lyketsos CG: A review of neuroimaging findings of apathy in Alzheimer's disease. Int Psychogeriatr 26: 195-207, 2014
14)Marshall GA, Donovan NJ, Lorius N, Gidicsin CM, Maye J, et al: Apathy is associated with increased amyloid burden in mild cognitive impairment. J Neuropsychiatry Clin Neurosci 25: 302-307, 2013
15)Mori T, Shimada H, Shinotoh H, Hirano S, Eguchi Y, et al: Apathy correlates with prefrontal amyloid β deposition in Alzheimer's disease. J Neurol Neurosurg Psychiatry 85: 449-455, 2014
16)Okada K, Kobayashi S, Yamagata S, Takahashi K, Yamaguchi S: Poststroke apathy and regional cerebral blood flow. Stroke 28: 2437-2441, 1997
17)Onoda K, Kuroda Y, Yamamoto Y, Abe S, Oguro H, et al: Post-stroke apathy and hypoperfusion in basal ganglia: SPECT study. Cerebrovasc Dis 31: 6-11, 2011
18)Hollocks MJ, Lawrence AJ, Brookes RL, Barrick TR, Morris RG, et al: Differential relationships between apathy and depression with white matter microstructural changes and functional outcomes. Brain 138: 3803-3815, 2015
19)Pagonabarraga J, Kulisevsky J, Strafella AP, Krack P: Apathy in Parkinson's disease: clinical features, neural substrates, diagnosis, and treatment. Lancet Neurol 14: 518-531, 2015
20)Reijnders JS, Scholtissen B, Weber WE, Aalten P, Verhey FR, et al: Neuroanatomical correlates of apathy in Parkinson's disease: a magnetic resonance imaging study using voxel-based morphometry. Mov Disord 25: 2318-2325, 2010
21)Baggio HC, Segura B, Garrido-Millan JL, Marti MJ, Compta Y, et al: Resting-state frontostriatal functional connectivity in Parkinson's disease-related apathy. Mov Disord 30: 671-679, 2015
I-FP-CIT SPECT study. Mov Disord 24: 2097-2103, 2009
23)Cummings JL, Mega M, Gray K, Rosenberg-Thompson S, Carusi DA, et al: The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology 44: 2308-2314, 1994
24)博野信次, 森 悦朗, 池尻義隆, 今村 徹, 下村辰雄, 他: 日本語版Neuropsychiatric Inventory痴呆の精神症状評価法の有用性の検討. 脳神経49: 266-271, 1997
25)日本脳卒中学会Stroke Scale委員会: 日本脳卒中学会・脳卒中感情障害（うつ・情動障害）スケール. 脳卒中25: 206-214, 2003
26)Toba K, Nakai R, Akishita M, Iijima S, Nishinaga M: Vitality Index as a useful tool to assess elderly with dementia. Geriatrics ＆ Gerontology International 2: 23-29, 2002
27)加藤元一郎, 注意・意欲評価法作製小委員会: 標準注意検査法（CAT）と標準意欲評価法（CAS）の開発とその経過. 高次脳機能研究26: 310-319, 2006
28)Marin RS, Biedrzycki RC, Firinciogullari S: Reliability and validity of the Apathy Evaluation Scale. Psychiatry Res 38: 143-162, 1991
29)葛西真理, 目黒謙一, 中村 馨: Apathy Evaluation Scale介護者評価の日本語版（AES-I-J）作成. 日老医誌51: 445-452, 2014
30)Starkstein SE, Mayberg HS, Preziosi TJ, Andrezejewski P, Leiguarda R, et al: Reliability, validity, and clinical correlates of apathy in Parkinson's disease. J Neuropsychiatry Clin Neurosci 4: 134-139, 1992
31)岡田和悟, 小林祥泰, 青木 耕, 須山信夫, 山口修平: やる気スコアを用いた脳卒中後の意欲低下の評価. 脳卒中20: 318-323, 1998
32)Robert PH, Clairet S, Benoit M, Koutaich J, Bertogliati C, et al: The apathy inventory: assessment of apathy and awareness in Alzheimer's disease, Parkinson's disease and mild cognitive impairment. Int J Geriatr Psychiatry 17: 1099-1105, 2002
33)Strauss ME, Sperry SD: An informant-based assessment of apathy in Alzheimer disease. Neuropsychiatry Neuropsychol Behav Neurol 15: 176-183, 2002
34)Starkstein SE, Ingram L, Garau ML, Mizrahi R: On the overlap between apathy and depression in dementia. J Neurol Neurosurg Psychiatry 76: 1070-1074, 2005
35)Sockeel P, Dujardin K, Devos D, Denève C, Destée A, et al: The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease. J Neurol Neurosurg Psychiatry 77: 579-584, 2006
36)Malloy P, Grace J: A review of rating scales for measuring behavior change due to frontal systems damage. Cogn Behav Neurol 18: 18-27, 2005
37)Guercio BJ, Donovan NJ, Munro CE, Aghjayan SL, Wigman SE, et al: The apathy evaluation scale: a comparison of subject, informant, and clinician report in cognitively normal elderly and mild cognitive impairment. J Alzheimers Dis 47: 421-432, 2015
38)Yamagata S, Yamaguchi S, Kobayashi S: Impaired novelty processing in apathy after subcortical stroke. Stroke 35: 1935-1940, 2004
39)Sawa M, Yamashita H, Fujimaki K, Okada G, Takahashi T, et al: Depressive symptoms and apathy are associated with psychomotor slowness and frontal activation. Eur Arch Psychiatry Clin Neurosci 262: 493-499, 2012
40)Kuhlmei A, Walther B, Becker T, Müller U, Nikolaus T: Actigraphic daytime activity is reduced in patients with cognitive impairment and apathy. Eur Psychiatry 28: 94-97, 2013
41)van Reekum R, Stuss DT, Ostrander L: Apathy: why care? J Neuropsychiatry Clin Neurosci 17: 7-19, 2005
42)Cipriani G, Lucetti C, Danti S, Nuti A: Apathy and dementia. Nosology, assessment and management. J Nerv Ment Dis 202: 718-724, 2014
43)Starkstein SE, Jorge R, Mizrahi R, Robinson RG: A prospective longitudinal study of apathy in Alzheimer's disease. J Neurol Neurosurg Psychiatry 77: 8-11, 2006
44)羽生春夫: MCI（Mild Cognitive Impairment）の概念と症候. Brain Nerve 62: 719-725, 2010
45)Robert PH, Berr C, Volteau M, Bertogliati-Fileau C, Benoit M, et al: Importance of lack of interest in patients with mild cognitive impairment. Am J Geriatr Psychiatry 16: 770-776, 2008
46)Yamagami T, Harada K, Hashidate H, Asakawa Y, Nihei K, et al: Obtaining information from family caregivers is important to detect behavioral and psychological symptoms and caregiver burden in subjects with mild cognitive impairment. Dement Geriatr Cogn Dis Extra 6: 1-9, 2016
47)Caeiro L, Ferro JM, Costa J: Apathy secondary to stroke: a systemic review and meta-analysis. Cerebrovasc Dis 35: 23-39, 2013
48)van Dalen JW, Molle van Charante EP, Nederkoorn PJ, van Gool WA, Richard E: Poststroke apathy. Stroke 44: 851-860, 2013
49)Staekenborg SS, Su T, van Straaten EC, Lane R, Scheltens P, et al: Behavioural and psychological symptoms in vascular dementia; differences between small- and large-vessel disease. Neurol Neurosurg Psychiatry 81: 547-551, 2010
50)Makin SD, Turpin S, Dennis MS, Wardlaw JM: Cognitive impairment after lacunar stroke: systematic review and meta-analysis of incidence, prevalence and comparison with other stroke subtypes. J Neurol Neurosurg Psychiatry 84: 893-900, 2013
51)Mayo NE, Fellows LK, Scott SC, Cameron J, Wood-Dauphinee S: A longitudinal view of apathy and its impact after stroke. Stroke 40: 3299-307, 2009
52)Moretti R, Torre P, Esposito F, Barro E, Tomietto P, et al: Apathy as a key symptom in behavior disorders: difference between Alzheimer's disease and subcortical vascular dementia. Zerr I (ed): Understanding Alzheimer's Disease. InTech, Rijeka, 2013, pp359-373, 2013
53)Berg D: Marker for a preclinical diagnosis of Parkinson's disease as a basis for neuroprotection. J Neural Transm Suppl 71: 123-132, 2006
54)Barone P, Antonini A, Colosimo C, Marconi R, Morgante L, et al: The PRIAMO study: A multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson's disease. Mov Disord 24: 1641-1649, 2009
55)Santangelo G, Trojano L, Barone P, Errico D, Grossi D, et al: Apathy in Parkinson's disease: diagnosis, neuropsychological correlates, pathophysiology and treatment. Behav Neurol 27: 501-513, 2013
56)Pedersen KF, Alves G, Aarsland D, Larsen JP: Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study. J Neurol Neurosurg Psychiatry 80: 1279-1282, 2009
57)Burrell JR, Hodges JR, Rowe JB: Cognition in corticobasal syndrome and progressive supranuclear palsy: a review. Mov Disord 29: 684-693, 2014
58)Agosta F, Galantucci S, Svetel M, Lukić MJ, Copetti M, et al: Clinical, cognitive, and behavioural correlates of white matter damage in progressive supranuclear palsy. J Neurol 261: 913-924, 2014
59)Leroi I, Pantula H, McDonald K, Harbishettar V: Neuropsychiatric symptoms in Parkinson's Disease with mild cognitive impairment and dementia. Parkinsons Dis 2012: 308097, 2012［doi: 10.1155/2012/308097］
60)Fitts W, Weintraub D, Massimo L, Chahine L, Chen-Plotkin A, et al: Caregiver report of apathy predicts dementia in Parkinson's disease. Parkinsonism Relat Disord 21: 992-995, 2015
61)Savica R, Grossardt BR, Bower JH, Boeve BF, Ahlskog JE, et al: Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol 70: 1396-1402, 2013
62)Klatka LA, Louis ED, Schiffer RB: Psychiatric features in diffuse Lewy body disease: a clinicopathologic study using Alzheimer's disease and Parkinson's disease comparison groups. Neurology 47: 1148-1152, 1996
63)Ricci M, Guidoni SV, Sepe-Monti M, Bomboi G, Antonini G, et al: Clinical findings, functional abilities and caregiver distress in the early stage of dementia with Lewy bodies (DLB) and Alzheimer's disease (AD). Arch Gerontol Geriatr 49: e101-e104, 2009
64)Bjoerke-Bertheussen J, Ehrt U, Rongve A, Ballard C, Aarsland D: Neuropsychiatric symptoms in mild dementia with lewy bodies and Alzheimer's disease. Dement Geriatr Cogn Disord 34: 1-6, 2012
65)岡田和悟, 山口修平: Lewy小体型認知症の神経心理学的検討. 診断と治療103: 1395-1399, 2015
66)Mendez MF, Shapira JS, Woods RJ, Licht EA, Saul RE: Psychotic symptoms in frontotemporal dementia: prevalence and review. Dement Geriatr Cogn Disord 25: 206-211, 2008
67)Neary D, Snowden JS, Gustafson L, Passant U, Stuss D, et al: Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51: 1546-1554, 1998
68)Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, et al: Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain 134: 2456-2477, 2011
69)Perri R, Monaco M, Fadda L, Caltagirone C, Carlesimo GA: Neuropsychological correlates of behavioral symptoms in Alzheimer's disease, frontal variant of frontotemporal, subcortical vascular, and lewy body dementias: a comparative study. J Alzheimers Dis 39: 669-677, 2014
70)Mikami K, Jorge RE, Moser DJ, Arndt S, Jang M, et al: Prevention of poststroke apathy using escitalopram or problem-solving therapy. Am J Geriatr Psychiatry 21: 855-862, 2013
71)Skidmore ER, Whyte EM, Butters MA, Terhorst L, Reynolds CF 3rd: Strategy training during inpatient rehabilitation may prevent apathy symptoms after acute stroke. PM R 7: 562-570, 2015
72)Lane-Brown AT, Tate R: Apathy after acquired brain impairment: a systematic review of non-pharmacological interventions. Neuropsychol Rehabil 19: 481-516, 2009
73)Ferrero-Arias J, Goñi-Imízcoz M, González-Bernal J, Lara-Ortega F, da Silva-González A, et al: The efficacy of nonpharmacological treatment for dementia-related apathy. Alzheimer Dis Assoc Disord 25: 213-219, 2011
74)蜂須賀研二: リハビリテーション医療におけるアパシーとその対策. 高次脳機能研究34: 184-192, 2014
75)生駒一憲: アパシー（意欲障害）のリハビリテーション. 小林祥泰（編）: 脳疾患によるアパシー（意欲障害）の臨床. 新興医学出版社, 東京, 2008, pp162-167
76)Brodaty H, Burns K: Nonpharmacological management of apathy in dementia: a systematic review. Am J Geriatr Psychiatry 20: 549-564, 2012
77)Birks J: Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database Syst Rev, CD005593, 2006
78)Cummings J, Lai TJ, Hemrungrojn S, Mohandas E, Yun Kim S, et al: Role of donepezil in the management of neuropsychiatric symptoms in Alzheimer's disease and dementia with Lewy bodies. CNS Neurosci Ther 22: 159-166, 2016
79)Clerici F, Vanacore N, Elia A, Spila-Alegiani S, Pomati S, et al: Memantine effects on behaviour in moderately severe to severe Alzheimer's disease: a post-marketing surveillance study. Neurol Sci 33: 23-31, 2012
80)Matsuzono K, Hishikawa N, Ohta Y, Yamashita T, Deguchi K, et al: Combination therapy of cholinesterase inhibitor (donepezil or galantamine) plus memantine in the Okayama Memantine Study. J Alzheimers Dis 45: 771-780, 2015
81)Seltzer B, Zolnouni P, Nunez M, Goldman R, Kumar D: Efficacy of donepezil in early-stage Alzheimer disease: a randomized placebo-controlled trial. Arch Neurol 61: 1852-1856, 2004
82)岡田和悟: 脳血管性アパシー（意欲障害）の治療. 小林祥泰（編）: 脳疾患によるアパシー（意欲障害）の臨床. 新興医学出版社, 東京, 2008, pp133-139
83)Kohno N, Abe S, Toyoda G, Oguro H, Bokura H, et al: Successful treatment of post-stroke apathy by the dopamine receptor agonist ropinirole. J Clin Neurosci 17: 804-806, 2010
84)Sami MB, Faruqui R: The effectiveness of dopamine agonists for treatment of neuropsychiatric symptoms post brain injury and stroke. Acta Neuropsychiatr 27: 317-326, 2015
85)Blundo C, Gerace C: Dopamine agonists can improve pure apathy associated with lesions of the prefrontal-basal ganglia functional system. Neurol Sci 36: 1197-1201, 2015
86)豊田元哉, 雑賀玲子, 青山淳夫, 安部哲史, 三瀧真悟, 他: 脳梗塞後のアパシーに対するシロスタゾールの効果. 脳卒中33: 182-184, 2011
87)Whyte EM, Lenze EJ, Butters M, Skidmore E, Koenig K, et al: An open-label pilot study of acetylcholinesterase inhibitors to promote functional recovery in elderly cognitively impaired stroke patients. Cerebrovasc Dis 26: 317-321, 2008
88)Czernecki V, Pillon B, Houeto JL, Pochon JB, Levy R, et al: Motivation, reward, and Parkinson's disease: influence of dopatherapy. Neuropsychologia 40: 2257-2267, 2002
89)Leentjens AF, Koester J, Fruh B, Shephard DT, Barone P, et al: The effect of pramipexole on mood and motivational symptoms in Parkinson's disease: a meta-analysis of placebo-controlled studies. Clin Ther 31: 89-98, 2009
90)Mori E, Ikeda M, Kosaka K, Donepezil-DLB Study Investigators: Donepezil for dementia with Lewy bodies: a randomized, placebo-controlled trial. Ann Neurol 72: 41-52, 2012
91)Devos D, Moreau C, Maltête D, Lefaucheur R, Kreisler A, et al: Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial. J Neurol Neurosurg Psychiatry 85: 668-674, 2014
92)Stinton C, McKeith I, Taylor JP, Lafortune L, Mioshi E, et al: Pharmacological management of Lewy body dementia: a systematic review and meta-analysis. Am J Psychiatry 172: 731-742, 2015
掲載誌情報
